针对脏的智能抗生素发现:多种机制的肺性炎治疗治疗的肺性
Lei Tian1,2, Taotao Qiang1, Juan Xia3
1College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an 710021, China.
Journal of medicinal chemistry
|January 15, 2025
概括
新抗生素候选物8i通过破坏蛋白质合成和破坏膜来向耐药细菌. 这种针对器官的新方法在治疗全身性感染和炎炎方面显示出有前途,毒性降低.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 多药耐药 (MDR) 细菌对全球健康构成重大挑战,需要开发新型抗生素.
- 乐法穆林 (Lefamulin) 是一种多发性菌素,它提供了一个新的机制,但在药理动力学和器官毒性方面面临着局限性.
- 对莱法穆林的修改对于增强其对抗耐药病原体的治疗潜力至关重要.
研究的目的:
- 设计和合成具有改善药理动力学特性和有针对性的器官输送的新型肺素衍生物.
- 评估这些衍生品对一系列MDR细菌的疗效,包括非典型的病原体.
- 阐明作用机制并评估有前途的候选人的安全概况.
主要方法:
- 通过四级化和结合刚性碎片,对莱法穆林的C14侧链进行化学修饰.
- 在体外测试合成的化合物对MDR细菌,Mycoplasma和Chlamydophila.
- 通过有机阴离子载体 (OCT) 评估器官向的评估和药物动力学性质的评估.
- 在体内研究以确定治疗系统性感染和炎炎的疗效,并评估毒性.
主要成果:
- 候选人8i,一个四分化的imidazo[4,5-c]pyridine pleuromutilin,在低度下对MDR细菌表现出广泛的活性.
- 8i通过50S核糖体子单元向受感染的脏提供向的药物,破坏生物膜,损伤膜,并抑制通过50S核糖体子单元合成蛋白质.
- 该化合物显示出快速清除,这表明长期器官毒性的潜在降低.
- 在临床前模型中,每日短时间注射8i在治疗全身感染和炎症上被证明是有效的.
结论:
- 新型四分化流素衍生物8i对MDR细菌和非典型病原体表现出强烈的活性.
- 在OCT中介的,针对器官的输送是增强抗生素疗效和降低毒性的一种有前途的战略.
- 这种方法为开发有效治疗具有挑战性的抗生素耐药性感染提供了新的途径.
相关概念视频
00:57Antibiotic Selection
52.2K
Overview
52.2K
01:15Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
325
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
325
01:28Renal Drug Excretion: Tubular Secretion
117
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
117